Maha Yehia Kamel

478 total citations
22 papers, 337 citations indexed

About

Maha Yehia Kamel is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Maha Yehia Kamel has authored 22 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Maha Yehia Kamel's work include Liver Disease Diagnosis and Treatment (4 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Pancreatitis Pathology and Treatment (2 papers). Maha Yehia Kamel is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Pancreatitis Pathology and Treatment (2 papers). Maha Yehia Kamel collaborates with scholars based in Egypt, United States and Saudi Arabia. Maha Yehia Kamel's co-authors include Rehab Ahmed Rifaai, Mohamed A. Morsy, Entesar F. Amin, Salwa A. Ibrahim, Azza A. K. El‐Sheikh, Asmaa Mohamed Abdel‐Aziz, Mohamed Ibrahim, Walaa Yehia Abdelzaher, Nermeen N. Welson and Ayman Geddawy and has published in prestigious journals such as BioMed Research International, Biomedicine & Pharmacotherapy and Journal of Pharmacy and Pharmacology.

In The Last Decade

Maha Yehia Kamel

21 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maha Yehia Kamel Egypt 11 82 69 49 44 40 22 337
Salwa A. Ibrahim Egypt 9 74 0.9× 106 1.5× 61 1.2× 69 1.6× 55 1.4× 14 351
Babak Hajipour Iran 12 57 0.7× 88 1.3× 44 0.9× 47 1.1× 40 1.0× 28 355
Marwa M. M. Refaie Egypt 13 131 1.6× 121 1.8× 39 0.8× 31 0.7× 33 0.8× 30 480
Filiz Mercantepe Türkiye 11 62 0.8× 103 1.5× 42 0.9× 18 0.4× 52 1.3× 57 376
Asmaa M. A. Bayoumi Egypt 13 112 1.4× 89 1.3× 28 0.6× 38 0.9× 39 1.0× 26 408
Yeşim Öztaş Türkiye 12 122 1.5× 89 1.3× 37 0.8× 49 1.1× 34 0.8× 50 511
Sabahattin Muhtaroğlu Türkiye 10 49 0.6× 21 0.3× 23 0.5× 24 0.5× 55 1.4× 30 365
J Martínek Czechia 13 123 1.5× 22 0.3× 35 0.7× 77 1.8× 44 1.1× 53 434
Yıldız Öner-İyidoğan Türkiye 14 61 0.7× 40 0.6× 16 0.3× 19 0.4× 56 1.4× 21 392
Ümit Karayalçın Türkiye 15 98 1.2× 45 0.7× 23 0.5× 16 0.4× 99 2.5× 33 646

Countries citing papers authored by Maha Yehia Kamel

Since Specialization
Citations

This map shows the geographic impact of Maha Yehia Kamel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maha Yehia Kamel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maha Yehia Kamel more than expected).

Fields of papers citing papers by Maha Yehia Kamel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maha Yehia Kamel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maha Yehia Kamel. The network helps show where Maha Yehia Kamel may publish in the future.

Co-authorship network of co-authors of Maha Yehia Kamel

This figure shows the co-authorship network connecting the top 25 collaborators of Maha Yehia Kamel. A scholar is included among the top collaborators of Maha Yehia Kamel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maha Yehia Kamel. Maha Yehia Kamel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Refaie, Marwa M. M., et al.. (2024). Sacubitril/valsartan protective effect on induced intestinal ischemia/reperfusion injury via immune modulation of IL6/STAT1 pathway. Journal of Pharmacy and Pharmacology. 76(7). 788–797. 1 indexed citations
3.
Kamel, Maha Yehia, et al.. (2023). Protective effect of rivastigmine against lung injury in acute pancreatitis model in rats via Hsp 70/IL6/ NF-κB signaling cascade. International Journal of Immunopathology and Pharmacology. 37. 1200442900–1200442900. 3 indexed citations
5.
Ibrahim, Yasmine, et al.. (2021). Molecular mechanisms underlying the effect of diacerein on trichloroacetic acid–induced hepatic pre-neoplastic lesions in rats. Human & Experimental Toxicology. 40(12_suppl). S788–S803. 2 indexed citations
6.
Kamel, Maha Yehia, et al.. (2021). Muscle adaptation to sleeve gastrectomy: Potential role of nutritional supplementation and physical exercise. Acta Biochimica Polonica. 69(1). 37–50. 1 indexed citations
7.
Kamel, Maha Yehia, et al.. (2021). Role of IL-6/STAT3 pathway in mediating the protective effect of agomelatine against methotrexate-induced lung/intestinal tissues damage in rats. Immunopharmacology and Immunotoxicology. 44(1). 35–46. 6 indexed citations
8.
Kamel, Maha Yehia, et al.. (2020). The potential protective effect of modafinil in intestinal ischemic reperfusion-induced in rats. International Immunopharmacology. 88. 106983–106983. 10 indexed citations
9.
Kamel, Maha Yehia, et al.. (2020). Hydrogen sulfide renal protective effects: possible link between hydrogen sulfide and endogenous carbon monoxide in a rat model of renal injury. Cell Stress and Chaperones. 25(2). 211–221. 21 indexed citations
10.
Abdel‐Aziz, Asmaa Mohamed, et al.. (2020). Cilostazol protects against cyclophosphamide-induced ovarian toxicity in female rats: role of cAMP and HO-1. Toxicology Mechanisms and Methods. 30(7). 526–535. 29 indexed citations
11.
Ibrahim, Mohamed, et al.. (2018). Hepatic effect of sofosbuvir and daclatasvir in thioacetamide-induced liver injury in rats. Clinical and Experimental Hepatology. 4(3). 175–181. 10 indexed citations
12.
Kamel, Maha Yehia, et al.. (2018). Antioxidant, anti-inflammatory, and anti-apoptotic effects of zinc supplementation in testes of rats with experimentally induced diabetes. Applied Physiology Nutrition and Metabolism. 43(10). 1010–1018. 25 indexed citations
13.
Abdel‐Aziz, Asmaa Mohamed, et al.. (2017). Effect of Sofosbuvir Plus Daclatasvir in Hepatitis C Virus Genotype-4 Patients: Promising Effect on Liver Fibrosis. Journal of Clinical and Experimental Hepatology. 8(1). 15–22. 23 indexed citations
14.
Kamel, Maha Yehia, et al.. (2017). Eff ects of hemin, a heme oxygenase-1 inducer in L-arginine-induced acute pancreatitis and associated lung injury in adult male albino rats. Endocrine Regulations. 51(1). 20–30. 20 indexed citations
15.
Geddawy, Ayman, et al.. (2016). Effects of Liraglutide and Vitamin E in Fructose-Induced Metabolic Syndrome in Rats. Pharmacology. 99(1-2). 48–56. 8 indexed citations
16.
El‐Sheikh, Azza A. K. & Maha Yehia Kamel. (2016). Ginsenoside-Rb1 ameliorates lithium-induced nephrotoxicity and neurotoxicity: Differential regulation of COX-2/PGE2 pathway. Biomedicine & Pharmacotherapy. 84. 1873–1884. 16 indexed citations
18.
Kamel, Maha Yehia, et al.. (2016). Different effects of selective β1-adrenoceptor antagonists, nebivolol or atenolol in acetaminophen-induced hepatotoxicity of rats. Fundamental and Clinical Pharmacology. 31(2). 165–173. 17 indexed citations
19.
Morsy, Mohamed A., et al.. (2014). Sildenafil Ameliorates Gentamicin-Induced Nephrotoxicity in Rats: Role of iNOS and eNOS. Journal of Toxicology. 2014. 1–7. 37 indexed citations
20.
Morsy, Mohamed A., et al.. (2013). Curcumin Ameliorates Methotrexate-Induced Nephrotoxicity in Rats. Advances in Pharmacological Sciences. 2013. 1–7. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026